“…Although novel antibiotics and antimicrobial materials have made great strides in recent years, bacterial infection remains a clinical threat to human health. , It was reported that the number of deaths related to global antibiotic resistance will increase to 10 million per year by 2050 . Therefore, it is of great significance to develop safe, effective, less toxic, and nonantibiotic antibacterial strategies. , Traditional antibacterial polymer materials, including chlorhexidine, triclosan, polyethylenimide, etc., are mainly related to organelle modification and interference with bacterial intracellular biochemical pathways. − They play an antibacterial role through the destruction of cell membrane, genes, protease, and other active substances . However, the development of polymer antibacterial materials is constrained by the difficulties, such as severe toxicity, poor heat resistance, quick breakdown, and the potential to induce microbial resistance. − Alternatively, inorganic nanomaterials have been widely used in the field of tumor treatment and bacterial infection thanks to their low toxicity, good biocompatibility, easy modification, and large surface energy. − Recently, various inorganic nanomaterials have been synthesized, including noble metal-based nanomaterials, , transition-metal-based nanomaterials, and other metallic nanomaterials .…”